中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effect of Preoperative Immunonutrition in Upper Digestive Tract

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态招聘中
赞助商
Complexo Hospitalario Universitario de A Coruña

关键词

抽象

Randomized, double-blind, multicenter clinical trial that will evaluate the effects of immuno-nutrition in the preoperative period in patients with cancer of the upper digestive tract (esophagus, stomach, and pancreas). The aim is to compare the specific effect of the immunonutrients respect to an equivalent formula in caloric-protein value but without immunonutrients, in the surgical evolution of the cancer patient.

描述

Background:

Perioperative nutritional status is a key factor in the evolution, as well as, postoperative morbidity and mortality of cancer patients. Particularly, digestive neoplasms have a high risk of malnutrition and this is related to a higher rate of surgery complications and mortality in the postoperative period. The immunonutrition seems to modulate the immune system and the inflammatory response in patients operated on for digestive neoplasia. However, the results to date are controversial.

Aim:

To compare the effect of an immunomodulatory oral nutritional supplement (enriched in arginine, nucleotides, omega 3 fatty acids, olive oil polyphenols, L-carnitine, and antioxidants) against an equivalent in protein-energy without immunonutrients, administrated in the preoperative period, in the surgical evolution of the cancer patient with neoplasia of the upper digestive tract.

Methods:

It is a randomized, double-blind, multicenter clinical trial. 178 patients with neoplasms of the esophagus, stomach or pancreas, with indication of surgical treatment, will be included. The patients will be randomized into two groups (intervention group and control group) and both will receive 2 daily bricks of the assigned formula (with or without immunonutrients, respectively) 5 days prior to surgery. The main variables of the study are: appearance of infectious or noninfectious complications in the postoperative period, length of hospital stay, and mortality. These variables will be compared by group (immunonutrition vs. non immunonutrition).

日期

最后验证: 07/31/2019
首次提交: 07/15/2019
提交的预估入学人数: 07/17/2019
首次发布: 07/18/2019
上次提交的更新: 08/18/2019
最近更新发布: 08/19/2019
实际学习开始日期: 08/09/2019
预计主要完成日期: 08/09/2021
预计完成日期: 12/30/2021

状况或疾病

Immunonutrition
Gastric Cancer
Esophageal Cancer
Pancreas Cancer
Surgery--Complications

干预/治疗

Dietary Supplement: Immunonutrition

Dietary Supplement: Standard

-

手臂组

干预/治疗
Experimental: Immunonutrition
Oral nutritional supplement: hypercaloric and hyperproteic with immunonutrients: Arginine, nucleotides, omega-3, olive oil polyphenols, antioxidants and L-carnitine
Dietary Supplement: Immunonutrition
It is a hypercaloric and hyperproteic dietary supplement formulated with immunonutrients: Arginin, nucleotides, omega-3, olive oil polyphenols, antioxidants and L-carnitine
Placebo Comparator: Standard
Oral nutritional supplement: hypercaloric and hyperproteic without immunonutrients
Dietary Supplement: Standard
It is a hypercaloric and hyperproteic dietary supplement formulated without immunonutrients

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- Diagnosis of cancer of esophagus, stomach and / or pancreas, at any stage, proposed for surgery

- Signing informed consent

Exclusion Criteria:

- Pregnant or breastfeeding

- Advanced renal insufficiency prior to dialysis (GFR <25 ml / min)

- Allergy or intolerance to any of the components of the dietary supplement (including fish allergy)

- Patients with contraindications for enteral nutrition

结果

主要结果指标

1. Infectious complications [Up to 30 days post-operative]

2. Surgical fistulas [Up to 30 days post-operative]

次要成果指标

1. Mortality [Up to 30 days post-operative]

2. Length of hospital stay [Up to 30 days post-operative]

3. Weight loss [10 days Pre-operative]

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge